酪氨酸血症
酪氨酸转氨酶
点突变
生物
外显子
内含子
无义突变
分子生物学
基因
遗传学
等位基因
酪氨酸
突变
突变体
错义突变
生物化学
酶诱导剂
酶
作者
E. Natt,Kaichi Kida,M Odièvre,Maja Di Rocco,Gerd Scherer
标识
DOI:10.1073/pnas.89.19.9297
摘要
Tyrosinemia type II (Richner-Hanhart syndrome, RHS) is a disease of autosomal recessive inheritance characterized by keratitis, palmoplantar hyperkeratosis, mental retardation, and elevated blood tyrosine levels. The disease results from deficiency in hepatic tyrosine aminotransferase (TAT; L-tyrosine:2-oxoglutarate aminotransferase, EC 2.6.1.5), a 454-amino acid protein encoded by a gene with 12 exons. To identify the causative mutations in five TAT alleles cloned from three RHS patients, chimeric genes constructed from normal and mutant TAT alleles were tested in directing TAT activity in a transient expression assay. DNA sequence analysis of the regions identified as nonfunctional revealed six different point mutations. Three RHS alleles have nonsense mutations at codons 57, 223, and 417, respectively. One "complex" RHS allele carries a GT----GG splice donor mutation in intron 8 together with a Gly----Val substitution at amino acid 362. A new splice acceptor site in intron 2 of the fifth RHS allele leads to a shift in reading frame.
科研通智能强力驱动
Strongly Powered by AbleSci AI